PMID: 6970629Jan 1, 1980Paper

Deoxycoformycin toxicity in mice after long-term treatment

Cancer Chemotherapy and Pharmacology
R P Agarwal

Abstract

Deoxycoformycin, a tight-binding inhibitor of the enzyme adenosine deaminase, is a potent lymphocytotoxic agent. To examine the effect of deoxycoformycin on mouse tissues the drug was administered IP either by single or by repeated injections at one of two dose levels (0.2 or 10.0 mg/kg). Treatment with repeated injections at the higher dose caused retardation of growth and increases in lung and splenic mass. Body temperature, hematocrit, and total leukocyte count remained constant. Single injections at the lower dose caused complete inhibition of adenosine deaminase in liver and blood, and partial inhibition in jejunum and spleen, but at the higher dose complete inhibition of the enzyme in all tissues was obtained. Dosage appeared to have no effect on the rate of recovery of the deoxycoformycin-inhibited enzyme but marked tissue differences were observed. The enzymic activity recovered rapidly in jejunum (100% in 1 day) but slowly in other tissues (after 28 days, about 60% in spleen and liver; about 85% in kidney and blood, and 100% in lungs). These observations suggest that the recovery of inhibited enzyme depends largely upon the rate of proliferation of cells and protein synthesis. These tissue differences in recovery rates...Continue Reading

References

Jan 1, 1978·Cancer Chemotherapy and Pharmacology·J F SmythD M Young
Mar 1, 1977·Biochemical Pharmacology·R P AgarwalR E Parks

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.